Estimated Control Closed Transaction verified ConsumerConsumer HealthcareConsumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
Boehringer Ingelheim Consumer Healthcare business acquired by Sanofi
Sanofi acquired Boehringer Ingelheim Consumer Healthcare business, a Global / Germany consumer healthcare / otc pharmaceuticals brand, on Jun 27, 2016.
Transaction summary
- Target
- Boehringer Ingelheim Consumer Healthcare business
- Acquirer
- Sanofi
- Seller
- Boehringer Ingelheim
- Announced
- 2016-06-27
- Geography
- Global / Germany
- Tags
- ConsumerConsumer HealthcareConsumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
USD 7.3B
100% enterprise value | USD
Basis: Estimated
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
4.4x
Period not stated
Basis: FundComb estimate
EV / EBITDA
16.1x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 7.3bn enterprise value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
- Valuation covers 100% of the target; the amount invested or paid for a stake is separate.
- EV / revenue: 4.4x.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- User-supplied spreadsheet economics; no revenue or EBITDA amount derived because period and value basis are not publicly confirmed in the supplied evidence.
Source summary
No public source summary has been published for this transaction yet.